在大鼠中,α1腺素受体对抗剂普拉佐辛增强了吗啡诱导的有条件位置偏好
Wanyu Tu1, Tengteng Zhang1, Chenchen Li1
1Xinxiang Key Laboratory of Forensic Toxicology, School of Forensic Medicine, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Brain research
|October 2, 2023
概括
普拉佐辛是一种α1 adrenoceptor对抗剂,通过影响大鼠的北上腺素水平和突触可塑性,增强了吗啡成. 这表明北上腺素系统是吗啡成的治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 上腺素 (NE) 系统在调节吗啡成方面发挥作用.
- 在侧轨道皮层 (VLO) 的α1上腺受体在吗啡成中的特定参与尚未完全理解.
研究的目的:
- 为了研究alpha1 adrenoceptor在VLO中的作用,在老鼠中进行多次吗啡治疗.
- 阐明潜在的分子机制,包括突触可塑性和炎症反应.
主要方法:
- 有条件的位置偏好 (CPP) 范式来评估吗啡奖励.
- 微注射普拉佐辛 (一种α1上腺受体对手) 进入VLO.
- 免疫组织化学和西部抹迹测量蛋白质表达 (alpha1 上腺受体,p-CaMKII/CaMKII,CRTC1,BDNF,PSD95).
- 高性能液体色谱 (HPLC) 用于NE检测和ELISA用于炎症因素.
主要成果:
- 重复的吗啡给药诱导了稳定的CPP,这被VLO普拉佐辛微注射增强了.
- 普拉佐辛阻断了α1上腺受体活性,降低了CaMKII酸化和CRTC1,并降低了突触可塑性蛋白.
- 普拉佐辛治疗降低了VLO中的NE,并增加了外周炎性细胞因子.
结论:
- 普拉佐辛增强了吗啡的成作用,这表明VLO中的α1上腺受体和NE具有关键作用.
- 观察到的效应与CaMKII-CRTC1通路,突触可塑性和外周炎症有关.
- NE系统为吗啡成提供了潜在的治疗标,在滥用吗啡的患者中临床使用普拉佐辛需要谨慎.
更多相关视频
07:05Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
6.0K
07:23Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
33.4K
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Opioid Receptors: Overview
984
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
984
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
289
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
289
